L. Foroni

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Dragana Milojković, Emma Nicholson, Jane F. Apperley et al. · Haematologica · 2009 · 123 citations · Full text

Medicine, Oncology, Pharmacology +14

The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib

Jamshid S. Khorashad, Simon D. Wagner, L. Greener et al. · Haematologica · 2009 · 10 citations · Full text

Medicine, Hematology, Oncology +15

P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE

Andrew J. Innes, Victoria Orovboni, Simone Claudiani et al. · HemaSphere · 2022 · 10 citations · Full text

Medicine, Hematology, Pharmacology +9